RSK inhibitor LJI308, Purity ≥98%

Cat. No.: X24-05-ZQ242

RSK inhibitor LJI308, Purity ≥98%

Synonym: 1627709-94-7; LJI 308; LJI-30; RSK inhibitor

  • CAS Number: 1627709-94-7
  • Compound CID: 118704762
Product Size
5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
LJI308, soluble in warmed DMSO and insoluble in water and ethanol, attenuates the activity of kinases involved in cell growth, survival, and proliferation, which can be utilized to inhibit tumor progression. It targets RSK1, RSK2, and RSK3.
Molecular Weight
368.38
Molecular Formula
C21H18F2N2O2
Targets
RSK1: 6 nM; RSK2: 4 nM; RSK3: 13 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 66 mg/mL (179.16 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LJI308 can be used in studies focusing on specific kinase inhibitory effects in various cellular processes.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.